Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of ATXS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Astria Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 13G/A | 6.61%3.78M shares | +1.08 ppfrom 5.53% | Dec 10, 20252 filings | Feb 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
80 Schedule 13D and 13G filings on Astria Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20264:10 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 0.00%0 shares | −8.80 ppfrom 8.80%Below 5% | Dec 31, 2025 | SEC |
| Feb 12, 20264:58 PM ET | Glazer Capital, LLCand 1 other | 13G/A | 6.61%3.78M shares | +1.08 ppfrom 5.53% | Dec 31, 2025 | SEC |
| Feb 9, 20265:03 PM ET | Perceptive Advisors LLCand 3 others | 13D/A | 0.00%0 shares | −11.50 ppfrom 11.50%Below 5% | Jan 26, 2026 | SEC |
| Jan 28, 20268:38 AM ET | Magnetar Financial LLCand 3 others | 13D/A | 0.00%0 shares | −5.87 ppfrom 5.87%Below 5% | Jan 26, 2026 | SEC |
| Dec 10, 20254:36 PM ET | Glazer Capital, LLCand 1 other | 13G | 5.53%3.16M shares | New | Dec 3, 2025 | SEC |
| Nov 14, 20254:02 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 8.80%4.96M shares | – | Sep 30, 2025 | SEC |
| Nov 14, 20259:46 AM ET | ForGrowth III PA B.V.and 2 others | 13G/A | 0.00%0 shares | −6.80 ppfrom 6.80%Below 5% | Oct 16, 2025 | SEC |
| Nov 7, 202511:13 AM ET | FMR LLCand 1 other | 13G/A | 2.20%1.25M shares | −6.90 ppfrom 9.10%Below 5% | Oct 31, 2025 | SEC |
| Nov 5, 202511:26 AM ET | FMR LLCand 1 other | 13G/A | 9.10%5.15M shares | −3.20 ppfrom 12.30% | Sep 30, 2025 | SEC |
| Oct 24, 202511:00 AM ET | Magnetar Financial LLCand 3 others | 13D | 5.87%3.31M shares | New | Oct 17, 2025 | SEC |
| Oct 20, 20254:23 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 0.40%222.1K shares | −4.80 ppfrom 5.20%Below 5% | Oct 14, 2025 | SEC |
| Oct 16, 20258:52 PM ET | Perceptive Advisors LLCand 3 others | 13D/A | 11.50%6.49M shares | – | Oct 14, 2025 | SEC |
| Oct 15, 20259:27 AM ET | Fairmount Funds Management LLCand 1 other | 13G/A | 4.00%2.38M shares | −5.90 ppfrom 9.90%Below 5% | Oct 14, 2025 | SEC |
| Aug 14, 20255:56 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2025 | SEC |
| Jun 18, 20254:03 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 5.20%2.94M shares | +1.70 ppfrom 3.50% | Jun 13, 2025 | SEC |
| May 15, 20258:45 AM ET | ForGrowth III PA B.V.and 2 others | 13G/A | 6.80%3.82M shares | +1.70 ppfrom 5.10% | Mar 31, 2025 | SEC |
| May 12, 202510:10 AM ET | FMR LLCand 1 other | 13G/A | 12.30%6.94M shares | −1.60 ppfrom 13.90% | Mar 31, 2025 | SEC |
| Feb 14, 20256:13 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 4.40%2.46M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20253:45 PM ET | Fairmount Funds Management LLCand 1 other | 13G/A | 9.90%5.87M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20258:46 AM ET | FMR LLCand 1 other | 13G/A | 13.90%7.82M shares | – | Dec 31, 2024 | SEC |
| Jan 28, 20254:00 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 3.50%1.99M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 7, 20257:45 AM ET | ForGrowth III PA B.V.and 2 others | 13G | 5.10%2.87M shares | New | Dec 30, 2024 | SEC |
| Nov 14, 2024 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Fairmount Funds Management LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Vestal Point Capital, LP | 13GOld format | – | New | – | SEC |
| Nov 13, 2024 | TCG Crossover GP II, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 1, 2024 | Integrated Core Strategies (US) LLC | 13GOld format | – | New | – | SEC |
| Oct 24, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Jul 10, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Mar 11, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Mar 7, 202412:29 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Fairmount Funds Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vivo Opportunity, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 12, 2024 | Ra Capital Management, L.P. | 13GOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2024 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Jan 29, 20245:26 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jan 16, 2024 | TCG Crossover GP II, LLC | 13GOld format | – | New | – | SEC |
| Jan 2, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell Astria Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Apr 1, 20244:58 PM ET | Chris MorabitoOfficer | 10.0K | $135.9K | Apr 1, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 29, 20244:39 PM ET | Christopher MorabitoOfficer | 9.20K | $102.6K | Jan 29, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |